a Clinical Study.the Effect of Addition of Insoluble Antibacterial Nanoparticles(IABN) in Resin Base Provisional Cement
IABN
Clinical Study :The Effect of Antibacterial Nanoparticles, Incorporated in Provisional Resin Based Cement, on S.Mutans in the Margins of Provisional Restorations
1 other identifier
observational
10
1 country
1
Brief Summary
The effect of Antibacterial Nanoparticles, Incorporated in cement, on S.mutans in the margins of provisional restorations is going to be examined clinically by using two kinds of provisional cement 1. cement with out antibacterial nanoparticles. 2.cement with small addition of IABN. after one week in the mouth the crowns are to be removed and examined for the presence and quantity of s. mutans. in vitro tests of the same has shown significant reduction in bacterial population around the provisional cement as compared to the regular cement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 16, 2007
CompletedFirst Posted
Study publicly available on registry
July 17, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJanuary 6, 2010
October 1, 2009
3.8 years
July 16, 2007
January 5, 2010
Conditions
Keywords
Study Arms (1)
patients with provisional crowns
the same patient would serve as control and test
Eligibility Criteria
hadassah dental patients
You may qualify if:
- Patients who need provisional restorations.
You may not qualify if:
- Patients who got antibacterial therapy in the past 3 months.
- Patients using chlorhexidine gluconate.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization,
Jerusalem, Israel
Related Publications (1)
Beyth N, Yudovin-Farber I, Bahir R, Domb AJ, Weiss EI. Antibacterial activity of dental composites containing quaternary ammonium polyethylenimine nanoparticles against Streptococcus mutans. Biomaterials. 2006 Jul;27(21):3995-4002. doi: 10.1016/j.biomaterials.2006.03.003. Epub 2006 Mar 27.
PMID: 16564083RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Perez Davidi, DMD
Hadassah Medical Organization
- STUDY DIRECTOR
Nir Sterer, DMD PhD
Hadassah Medical Organization
- STUDY CHAIR
Ervin Weiss, DMD
Hadassah Medical Organization
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 16, 2007
First Posted
July 17, 2007
Study Start
February 1, 2007
Primary Completion
December 1, 2010
Study Completion
December 1, 2011
Last Updated
January 6, 2010
Record last verified: 2009-10